Whitehawk Therapeutics (WHWK) Net Equity Issued and Repurchased (2017 - 2020)

Whitehawk Therapeutics' (WHWK) quarterly Net Equity Issued and Repurchased came in at $9.3 million in Q3 2020, up 40.42% on a QoQ basis from $6.6 million in Q3 2018.

Whitehawk Therapeutics (WHWK) Net Equity Issued and Repurchased (2017 - 2020) Analysis & Trends

Whitehawk Therapeutics (WHWK) has 3 years of Net Equity Issued and Repurchased data on file, last reported at $9.3 million in Q3 2020.

  • On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $9.3 million in Q3 2020; TTM through Dec 2022 was $9.3 million, a 0.0% change from a year earlier, with the FY2021 full-year figure at $155.0 million, up 1490.78% from the prior year.
  • Net Equity Issued and Repurchased for Q3 2020 stood at $9.3 million, up from $6.6 million in the prior quarter.
  • Over the last five years, Net Equity Issued and Repurchased for WHWK reached as high as $40.2 million in Q1 2017 and fell as low as $2.0 in Q4 2017.
  • Historically, Net Equity Issued and Repurchased has averaged $14.0 million across 3 years, with a median of $8.0 million in 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 Whitehawk Therapeutics 34.18 Mn 34.18 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2020 9.30 Mn
Sep 30, 2020 9.30 Mn
Sep 30, 2018 6.62 Mn
Sep 30, 2018 6.62 Mn
Dec 31, 2017 2.00
Dec 31, 2017 2.00
Mar 31, 2017 40.25 Mn
Mar 31, 2017 40.25 Mn